Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 April 2024 | Story VALENTINO NDABA | Photo Supplied
Human Rights Month Graphic
Empowering the youth to shape tomorrow’s democracy.

As South Africa prepares for its national elections scheduled for 29 May 2024, the University of the Free State (UFS) emphasises the importance of youth engagement in the democratic process. These sentiments were echoed during the Human Rights Day event recently hosted by the Free State Centre for Human Rights.

Exercising the right to vote

Aligned with the university’s Vision 130 strategy, which prioritises societal development, the UFS aims to educate and engage its community members on the significance of voting as a catalyst for positive change. Through initiatives like the Human Rights Day event, the university fosters awareness and advocacy for democratic principles, empowering individuals to exercise their right to vote and contribute to shaping the nation’s future.

Advocating for democratic principles

Dr Annelie De Man, Coordinator of the Advocacy Division at the Free State Centre for Human Rights, highlighted the relevance of the Human Rights Day event in light of the elections. “We celebrated Human Rights Day by raising awareness amongst our students regarding the rights that they possess including the right to vote, especially with the South African national elections approaching. We also wanted to convey the message that even though we as a country are experiencing many challenges, we still have our constitutionally guaranteed and hard fought-for rights that guarantee that our human dignity and right to equality must be respected.”

The event held on the Bloemfontein Campus served as a platform to raise awareness among students about their rights and the role of the Free State Centre for Human Rights. Limeque Redgard, a student assistant at the centre, described the event as an opportunity to educate students on human rights within the institution and to introduce them to available support mechanisms in case of rights violations.

Student-led advocacy

Badumetsie Tsieane, Executive Committee Chairperson of the Human Rights Ambassadors, noted the importance of making human rights discussions engaging for students and highlighted the role of ambassadors in promoting awareness and advocacy.

The event showcased the enthusiasm and commitment of students towards understanding and championing human rights, and also underscored the impact of initiatives like the Free State Centre for Human Rights in empowering the youth to participate actively in shaping a just and equitable society.

A call to action

As the nation gears up for the elections, UFS encourages students to exercise their democratic right to vote. Recognising the challenges faced by the country, the university reaffirms its commitment to promoting civic engagement and upholding the principles of human rights and democracy. With the support of initiatives like the Human Rights Day event, the UFS aims to equip students with the knowledge and awareness necessary to become informed and responsible citizens. By fostering a culture of engagement and advocacy, the university strives to contribute to the development of a vibrant and inclusive democracy in South Africa.

As the countdown to the elections continues, the UFS remains dedicated to empowering the youth to play an active role in shaping the future of the nation through their participation in the democratic process.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept